Coronary Calcium Score vs CCTA with Cleerly® Plaque Analysis: What Actually Measures Your Risk?
For years, the Coronary Calcium Score has been positioned as a powerful tool for assessing heart disease risk. And to be clear—it has value.
But in modern HormoneSynergy® Longevity Medicine, we have moved beyond asking:
“Is there calcium?”
The real question is:
“How much total plaque is there, what type is it, and how dangerous is it?”
That’s where Coronary CT Angiography (CCTA) with Cleerly® plaque analysis fundamentally changes the game.
Coronary Calcium Score: What It Measures
A Coronary Artery Calcium (CAC) Score is a non-contrast CT scan that detects calcified plaque in the coronary arteries.
It provides a single number:
- 0 → No detectable calcified plaque
- 1–99 → Mild plaque burden
- 100–399 → Moderate plaque burden
- 400+ → High plaque burden
It has been widely used because:
- It’s fast
- It’s relatively inexpensive
- It correlates with long-term cardiovascular risk
But Here’s the Problem
Calcium is not the whole story.
Calcium represents older, more stable plaque. It is essentially a marker of past disease progression—not necessarily current vulnerability.
And most importantly:
Calcium scoring does NOT detect soft plaque.
CCTA with Cleerly® Plaque Analysis: What It Actually Shows
Coronary CT Angiography (CCTA) is a contrast-enhanced CT scan that visualizes the coronary arteries in detail.
When paired with Cleerly® AI Plaque analysis, it becomes something entirely different:
- Quantifies total plaque burden
- Differentiates calcified vs non-calcified (soft) plaque
- Identifies high-risk plaque features
- Measures degree of narrowing (stenosis)
- Tracks plaque progression over time
This is not just detection—it’s disease mapping.
Why This Difference Matters (More Than Most Realize)
Most heart attacks do not come from heavily calcified, stable plaque.
They come from:
- Non-calcified (soft) plaque
- Inflamed, unstable lesions
- Plaque that may not yet be visible on a calcium score
This creates one of the most dangerous clinical blind spots:
A calcium score of zero does NOT mean zero risk.
We see this regularly:
- Normal cholesterol panels
- Low or zero CAC score
- But significant soft plaque on CCTA
That’s the gap between standard screening and true preventive cardiology.
Coronary Calcium Score vs CCTA: Side-by-Side
| Feature | Calcium Score (CAC) | CCTA with Cleerly® |
|---|---|---|
| Contrast Required | No | Yes |
| Detects Calcified Plaque | Yes | Yes |
| Detects Soft Plaque | No | Yes |
| Quantifies Total Plaque | No | Yes |
| Identifies High-Risk Plaque | No | Yes |
| Tracks Disease Progression | Limited | Yes |
The Cleerly® Plaque Analysis Difference
The addition of Cleerly® transforms CCTA from imaging into a quantitative disease model.
Instead of a simple visual read, Cleerly Plaque Analysis provides:
- Exact plaque volume measurements
- Plaque composition breakdown
- Percent stenosis by vessel
- AI-driven risk stratification
This allows for something that traditional cardiology rarely achieves:
Objective, trackable prevention.
Where Each Test Still Fits
Coronary Calcium Score
- Initial screening tool
- Population-level risk stratification
- Quick, low-cost assessment
CCTA with Cleerly®
- True plaque detection and characterization
- Early disease identification
- Precision-guided prevention strategies
- Monitoring response to treatment over time
Longevity Medicine Perspective
At HormoneSynergy®, we are not waiting for disease to become obvious.
We are identifying it when it is:
- Early
- Silent
- Reversible
That means looking beyond:
- “Normal” labs
- Traditional risk calculators
- And even calcium scores alone
Because prevention is not about guessing risk.
It’s about measuring disease.
Related Longevity Medicine Resources
Frequently Asked Questions
Is a calcium score of zero enough to rule out heart disease?
No. A calcium score of zero means no calcified plaque was detected, but it does not rule out soft plaque or early disease.
Is CCTA with Cleerly® necessary for everyone?
Not necessarily. It is most useful for individuals seeking deeper risk assessment, especially when traditional markers are inconclusive or risk is suspected despite “normal” labs.
Is CCTA safe?
Yes. It involves contrast and low-dose radiation, but when used appropriately, the clinical value significantly outweighs the risk.
Can plaque be reversed?
In many cases, plaque progression can be slowed, stabilized, and sometimes regressed with targeted interventions when identified early.